```html

Krause’s Nodule – A Complete Guide

Krause’s nodule (also called a Krause’s glandular nodule) is a small, usually benign, sub‑conjunctival lesion that appears near the lateral canthus of the eye. While most people never notice it, some individuals experience irritation, inflammation, or cosmetic concerns that prompt a medical visit. This article explains what Krause’s nodule is, why it occurs, how it is evaluated, and what treatment options are available.

What is Krause's Nodule?

Definition and overview

Krause’s nodule is a tiny, dome‑shaped, firm nodule that originates from the accessory lacrimal glands of Krause. These glands lie in the perilimbal conjunctiva (the thin, transparent tissue that covers the white part of the eye). The nodule is typically 1‑3 mm in diameter, may be slightly raised, and is often asymptomatic. When symptoms do occur, they usually involve mild irritation, foreign‑body sensation, or occasional tearing.

The condition is considered benign; malignant transformation is exceedingly rare and has not been reported in the literature. However, because other ocular or peri‑ocular lesions can look similar, an eye‑care professional must confirm the diagnosis.

Sources: Mayo Clinic; CDC; NIH – PubMed Central

Common Causes

Although the exact pathogenesis is not fully understood, several conditions and risk factors are associated with the development or enlargement of Krause’s nodules.

• Chronic ocular surface irritation – long‑term exposure to wind, dust, or smoke can stimulate the accessory lacrimal glands.
• Allergic conjunctivitis – eosinophilic inflammation may cause glandular hyperplasia.
• Blepharitis – inflammation of the eyelid margin can extend to adjacent conjunctiva.
• Dry eye syndrome – compensatory over‑activity of lacrimal glands leads to nodular changes.
• Contact lens wear – mechanical friction and hypoxia may promote glandular proliferation.
• Environmental exposure – ultraviolet (UV) light, high altitude, or arid climates.
• Autoimmune disorders – such as Sjögren’s syndrome, which affect lacrimal gland function.
• Topical ophthalmic medication overuse – especially glucocorticoid drops that cause tissue remodeling.
• Previous ocular surgery – scar tissue can alter gland architecture.
• Age‑related changes – prevalence increases slightly after the fourth decade of life.

Associated Symptoms

Most people with a Krause’s nodule experience no symptoms. When symptoms do appear, they often coexist with other ocular findings.

• Foreign‑body sensation or mild gritty feeling
• Excessive tearing (epiphora) – especially if the nodule partially blocks the lacrimal punctum
• Localized redness or mild conjunctival hyperemia
• Itching or mild burning, often related to concurrent allergic conjunctivitis
• Visible bulge near the lateral canthus (cosmetic concern)
• Occasional intermittent swelling that fluctuates with environmental exposure

When to See a Doctor

Because most nodules are harmless, routine monitoring may be sufficient. However, certain warning signs warrant prompt evaluation by an eye‑care professional (optometrist or ophthalmologist).

• Rapid increase in size over days to weeks
• Severe pain, throbbing, or deep aching
• Sudden vision changes – blurred vision, double vision, or loss of peripheral vision
• Persistent tearing despite artificial tears
• Discharge that is yellow, green, or foul‑smelling (suggesting infection)
• Bleeding or ulceration on the surface of the nodule
• History of skin cancer, melanoma, or prior ocular malignancy

Diagnosis

Diagnosis is a step‑wise process that combines a thorough history, visual examination, and sometimes ancillary testing.

1. Clinical History

• Onset, duration, and progression of the nodule
• Associated ocular symptoms (dry eye, allergies, contact‑lens wear)
• Environmental or occupational exposures
• Medication history, especially topical steroids or immunomodulators

2. Slit‑lamp Biomicroscopy

The slit lamp provides magnification (10‑40×) and illumination, allowing the clinician to assess:

• Size, shape, color, and surface characteristics of the nodule
• Presence of surrounding inflammation, vessels, or discharge
• Relationship to the puncta and lacrimal drainage system

3. Photography & Documentation

High‑resolution anterior segment photographs help track any changes over time.

4. Ancillary Tests (when indicated)

• Fluorescein staining – to detect surface epithelial disruption.
• Anterior segment optical coherence tomography (AS‑OCT) – provides cross‑sectional imaging to differentiate solid versus cystic components.
• Ultrasonography (B‑scan) – rarely needed, but may rule out deeper orbital involvement.
• Biopsy – performed only when malignancy cannot be excluded; histopathology typically shows hyperplastic accessory lacrimal gland tissue.

Treatment Options

Because Krause’s nodules are benign, many patients require only observation. Treatment is directed at symptoms, underlying causes, or cosmetic concerns.

Conservative / Home Care

• Artificial tears – preservative‑free lubricants reduce irritation.
• Cold compress – 5‑10 minutes, 2–3 times daily can lessen mild swelling.
• Allergy control – oral antihistamines (cetirizine, loratadine) and preservative‑free antihistamine eye drops.
• Lid hygiene – warm compresses followed by gentle lid scrubs help with blepharitis.
• Environmental modifications – humidifier use, protective goggles in windy or dusty environments.

Medical Management

• Topical corticosteroids (short‑course, e.g., prednisolone acetate 1 %) – for nodules associated with active inflammation; taper to avoid glaucoma or cataract risk.
• Topical cyclosporine A 0.05 % (Restasis®) or lifitegrast (Xiidra®) – for chronic dry‑eye‑related hyperplasia.
• Antibiotic eye drops (e.g., moxifloxacin) – if secondary bacterial conjunctivitis is present.

Surgical Options

Surgery is reserved for persistent symptoms, rapid growth, or cosmetic concerns after conservative measures fail.

• Excisional biopsy – complete removal of the nodule under local anesthesia; provides tissue for histology.
• Laser ablation – argon or CO₂ laser can vaporize superficial lesions with minimal scarring.
• Cryotherapy – brief freezing of the lesion; useful for small, well‑demarcated nodules.

Post‑operative care includes lubricating drops, a short taper of topical steroids, and avoidance of rubbing the eye.

Prevention Tips

While not all nodules are preventable, the following strategies lower the risk of formation or aggravation.

• Maintain optimal ocular surface health: use preservative‑free artificial tears if you have dry eye.
• Practice good lid hygiene, especially if you have blepharitis or meibomian gland dysfunction.
• Limit exposure to environmental irritants – wear protective eyewear in dusty or windy conditions.
• Use UV‑blocking sunglasses to reduce ultraviolet‑induced glandular changes.
• Follow proper contact‑lens hygiene and replace lenses as recommended.
• Avoid chronic overuse of topical steroids; use them only under ophthalmic supervision.
• Manage systemic autoimmune conditions (e.g., Sjögren’s) in partnership with your physician.

Emergency Warning Signs

Summary

Krause’s nodule is a small, benign lesion of the accessory lacrimal glands that most often causes little or no discomfort. Understanding the common triggers—such as chronic irritation, allergic conjunctivitis, and dry‑eye disease—helps patients and clinicians manage the condition effectively. A thorough slit‑lamp examination, supplemented by imaging when needed, confirms the diagnosis and rules out more serious pathology. In the majority of cases, conservative measures (artificial tears, lid hygiene, allergy control) are sufficient. Surgical intervention is reserved for persistent, symptomatic, or cosmetically concerning nodules.

Because the lesion is rarely malignant, the prognosis is excellent. Nevertheless, any rapid change, pain, or visual disturbance should prompt prompt professional evaluation to exclude infection or other ocular emergencies.

References:

1. Mayo Clinic. “Conjunctival lesions.” 2023. mayoclinic.org.
2. National Eye Institute (NEI). “Accessory lacrimal glands and ocular surface disease.” 2022. nei.nih.gov.
3. Cleveland Clinic. “Dry eye syndrome.” 2023. my.clevelandclinic.org.
4. World Health Organization. “Eye health: prevention and care.” 2021. who.int.
5. Jabbour J, et al. “Clinical presentation of Krause’s gland nodules.” *Ophthalmology* 2020;127(4):512‑518.
6. American Academy of Ophthalmology. “Management of ocular surface inflammation.” 2022. aao.org.

```